Medication Adherence to Successful Tuberculosis Treatment Outcome among TB/HIV Patient at Prof. Dr. Sulianti Saroso Infectious Disease Hospital

Tuberculosis/Human Immunodeficiency Virus (TB/HIV) co-infection has poorer treatment outcome compared to non-co-infected patients. To benefit from therapy and to avoid contracting treatment-resistant strains, the individuals must adherent to medications. There is limited information regarding successful TB treatment outcomes and their associated factors. Thus, the study was designed to identify medication adherence associated with treatment outcomes among TB/HIV Patients at Prof. Dr. Sulianti Saroso Infectious Disease Hospital. This research was an observational study with retrospective approach from January 2015 to December 2017 by taking data from medical records and TB-01 form of TB/HIV patients in the outpatient clinic of the disease which would be used as a sample. Regarding compliance in treatment with first visit for 2-4 months, an approach using secondary data which were TB-01 Form, as well as HIV Care and Antiretroviral Therapy summary forms was used. The statistical analysis used was the bivariate analysis with the chi-square test as the statistical test. A total of 114 patients were included in the study. The outcome of treatment success obtained from this study had a patient cure rate of 91.30%. There is a significant relationship between medication adherence to successful tuberculosis treatment outcome with p-value= 0.012; OR= 5.684. There is a meaningful relation between medication compliance with treatment outcome. It is when on medication adherence, the treatment results can be declared cured in accordance with predetermined criteria, while when not on medication adherence, the treatment results are not declared cured.

Comparison of Anti-Tuberculosis Treatment Outcomes of Pulmonary Tuberculosis in Current, Ex and Non Smokers

Objective: To detect treatment outcomes in current smokers, ex - smokers and nonsmokers, in newly diagnosed pulmonary TB patients. Methodology: This cohort prospective study was conducted in the department of Microbiology, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre Karachi, with the collaboration of different (DOTS) centers of Pathology Karachi Medical and Dental College, Karachi. All newly diagnosed pulmonary TB patients registered for treatment either of gender were included. The patients were divided into three groups. Group-A: Current smokers, Group-B: Ex-smokers, Group-C: Non-smokers. Patients were followed for 6 months. Outcome was assessed in terms of cured or failure. All the information was enrolled in pre-designed proforma. Data was analyzed by using SPSS version 20. Results: In current study mean age of non-smokers was 44.20±17.73, ex-smokers 43.13±15.67 years mean age of smokers was 38.07±15.67 years. Males were in majority in all study groups as in ex-smokers group, males were 98.75%, non-smoker males were 90.0% and in smoker group males were 92.50%. At starting of treatment, mean weight of smoker patients was 55.50±5.41 kg, ex-smoker’s 48.91±9.00 kg and mean weight of non-smokers 48.71±7.04 kg. P-0.001. At starting of treatment, the mean ESR of non-smokers was 89.31±10.02, ex-smoker’s was 82.62±12.18 and smokers ESR average was 80.61±15.83. P-0.001. After 6 month treatment, cured rate was (96.25%) in non-smokers, (90%) in smokers and (93.75%) in ex–smokers. Conclusion: This study concluded that cured rate was high in non-smokers. Smoking status in individuals greatly affects the tuberculosis treatment outcome with enhance failure rate.